Utility of Immediate Post Placental Insertion of Intrauterine Device During Cesarean Delivery

Immediate Post Placental Insertion of Intrauterine Device at Cesarean Delivery, is Acceptable, Feasible and Safe in Iraqi Women.

Iraq is a country that ranks 33rd around world population growth rate. Meanwhile it is one of the counties in the middle east with the highest fertility rate, In addition to the considerable number of unintended pregnancy mainly in postpartum period.

The less use of family planning methods, the higher the fertility rate and the less interpregnancy interval which will carry an obvious more risk to the mother and the fetus especially if the cesarean delivery rate shown an increase trend as the case in Iraq. For that reason, contraception needs to be practiced in this critical period and an intrauterine contraceptive device ( IUD), the most commonly used reversible method of contraception worldwide could be an excellent choice during this period.

There were few evidences available about the safety and feasibility on practicing this type of contraception when we did start three years ago and no previous evidences in Iraq about practicing this method at the immediate postpartum period.

Study Overview

• Status: Completed
• Conditions: Contraception Behavior
• Intervention / Treatment: Device: Copper Intra uterine contarceptive device ( Cu-T 380A)

Detailed Description

Setting and design:

It is a single arm prospective clinical trial. That had been conducted at Al Elweyia Maternity Teaching Hospital and Al Hayat Private Hospital in Baghdad during the period from Sept., 1st, 2015 to Jan.,1st, 2019. Women delivering in those hospitals fulfilling inclusion criteria were included in the study after obtaining informed consent. The study protocol was approved by the ethical committee.

Data collection:

180 women were enrolled in the study, only 150 of them completed the study as thirty women we couldn't reach them through their contact numbers.

Intervention:

They had immediate post-partum insertion of Copper IUD (Cu-T 380A) after delivery of placenta immediately at cesarean delivery. To overcome the considerable expulsion rate in the previous studies, we stabilize the IUD in place at the uterine fundus by an absorbable suture; vicryl 0 that was introduced through the fundus ( from out to in), held the needle with sponge holder that was introduce up the fundus and taken out the vicryl through the lower uterine incision, cutting the needle, warped the vicryl around the the T arm of the IUD and withdrawn back to be placed inside the uterine cavity near the fundus. Before closing the uterine incision, the threads were placed in the lower uterine segment, then the uterine incision was closed routinely.

Follow up:

Women were assessed before discharge from the hospital looking for any excessive bleeding and were provided with a mobile number to call, in case she has any problem with the device that had been inserted.

Women were reassessed at six weeks postpartum, where speculum examination was done and if IUD threads was seen, they were trimmed at 2 cm from external os, otherwise if the threads of IUD were not seen a pelvic ultrasonography was done to confirm the presence of IUD in situ.

Women then were reassessed at yearly intervals for 3 years, looking for the occurrence of excessive bleeding during subsequent menstruation, for abdominal pain and abnormal vaginal discharge, missed threads, expulsion rate, continuation rate and how far they do recommend this method of contraception for other women.

Statistical analysis:

The data analyzed using Statistical Package for Social Sciences (SPSS) version 25. The data presented as mean, standard deviation and ranges. Categorical data presented by frequencies and percentages. Chi square test was used to assess the association between complication of IUD and certain information. Significance level was set at P < 0.05.

• Study Type: Interventional
• Enrollment (Actual): 150
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Iraq
  • Baghdad, Iraq, 10096
    • Al Kindy College of Medicine/ University of Baghdad

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 45 years (ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Women who delivered by caesarean section whether elective or emergency, counseled for IUD insertion in pre- natal period or at the time of labour and who has the will and her husband to be engaged in the study.

Exclusion Criteria:

• Women with positive test for STIs (e.g. gonorrhea or chlamydia) in this pregnancy.
• Uterine anomaly that was known to distort the uterine cavity; whether uterine fibroid or congenital uterine anomalies.
• Developed postpartum hemorrhage.
• Diagnosed chorioamnionitis, intrapartum fever, or ruptured membranes for greater than 24 hours prior to delivery.
• Placenta previa or accrete.
• Anemia during pregnancy (Hb < 10 g/dl).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: PREVENTION
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

EXPERIMENTAL: Post placental intra uterine device insertion; There was immediate post-partum insertion of CuT 380 A intrauterine device after delivery of placenta during cesarean delivery. To overcome the considerable expulsion rate in the previous studies, we stabilize the IUD in place at the fundus be an absorbable suture; vicryl 0 that was introduced through the fundus, held the needle with sponge holder that was introduce up the fundus and taken out the vicryl through the lower uterine inscion, cutting the needle, hold the vicryl around the the T arm of the IUD and withdrawn back to be placed inside the fundus. Before closing the uterine incision, the threads were placed in the lower uterine segment, then the uterine incision was then closed routinely.

Device: Copper Intra uterine contarceptive device ( Cu-T 380A); Insertion of the Cu-T 380A during cesarean delivery immediately after placental removal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of the women accept to be engaged in this services.	Assessing the acceptability of the women for the service of IUD insertion during the immediate postpartum period after cesarean delivery.	First 6 months of the study
Cost of IUD insertion during the immediate postpartum period.	Assessing the cost for the insertion of the device in the immediate postpartum period.	Up to 3 years.
Time spent for IUD insertion during the immediate postpartum period	Assessing the extra time spent for the insertion of the device in the immediate postpartum period.	Up to 3 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of Immediate complications	Number of the women having immediate complications including excessive blood loss before discharge from the hospital.	First 48 hours post cesarean section.
Percentage of other complications	Number of the women having heavy menstrual blood loss, abdominal pain, abnormal vaginal discharge, missed threads, perforation and expulsion rate.	Six months and yearly up to 3 years

Collaborators and Investigators

• Sponsor: Taghreed Alhaidari
• Collaborators: Elweyia Maternity Teaching Hospital
• Investigators: Principal Investigator: Taghreed K Alhaidari, CABOG, Al Kindy College of Medicine, University of Baghdad; Principal Investigator: Asmaa T Majeed, FICOG, Al Kindy College of Medicine, University of Baghdad; Principal Investigator: Sahar J Al-Jassani, CABOG, Al Kindy College of Medicine, University of Baghdad; Principal Investigator: Hayder A Fawzi, FICMS, Department of Pharmacy, Al-Esraa University College

Study record dates

Study Major Dates

• Study Start (ACTUAL): September 1, 2015
• Primary Completion (ACTUAL): January 1, 2019
• Study Completion (ACTUAL): June 1, 2019

Study Registration Dates

• First Submitted: October 16, 2019
• First Submitted That Met QC Criteria: October 21, 2019
• First Posted (ACTUAL): October 23, 2019

Study Record Updates

• Last Update Posted (ACTUAL): January 18, 2020
• Last Update Submitted That Met QC Criteria: January 14, 2020
• Last Verified: January 1, 2020

More Information

Terms related to this study

• Keywords: Safety; Feasibility; Long acting reversible contraception; Post placental insertion of intrauterine device; Cesearean section
• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Trace Elements; Micronutrients; Copper
• Other Study ID Numbers: 9 Al-KindyCM

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No